恶唑烷二酮衍生的比卡鲁胺类似物的合成。
Synthesis of oxazolidinedione derived bicalutamide analogs.
作者信息
Nair Vipin A, Mustafa Suni M, Mohler Michael L, Dalton James T, Miller Duane D
机构信息
Department of Pharmaceutical Sciences, University of Tennessee, 847 Monroe Avenue, RM 227 C, Memphis, TN 38163, USA.
出版信息
Tetrahedron Lett. 2006 Jun 5;47(23):3953-3955. doi: 10.1016/j.tetlet.2006.03.146.
Abstract
The synthesis of chiral oxazolidinedione derived bicalutamide analogs has been discussed.
摘要
已对源自比卡鲁胺的手性恶唑烷二酮类似物的合成进行了讨论。
相似文献
1
Synthesis of oxazolidinedione derived bicalutamide analogs.恶唑烷二酮衍生的比卡鲁胺类似物的合成。
Tetrahedron Lett. 2006 Jun 5;47(23):3953-3955. doi: 10.1016/j.tetlet.2006.03.146.
2
Structure determination of chiral sulfoxide in diastereomeric bicalutamide derivatives.非对映体比卡鲁胺衍生物中手性亚砜的结构测定
Chirality. 2009 Jun;21(6):578-83. doi: 10.1002/chir.20642.
3
Optical biosensor analysis in studying new synthesized bicalutamide analogs binding to androgen receptor.用于研究新合成的比卡鲁胺类似物与雄激素受体结合的光学生物传感器分析。
J Pharm Biomed Anal. 2014 Jul;95:151-7. doi: 10.1016/j.jpba.2014.03.002. Epub 2014 Mar 12.
4
Effects of the oxazolidinedione anticonvulsants trimethadione and dimethadione and the barbiturate homolog 5,5-dimethylbarbituric acid on N-nitrosodiethylamine-initiated renal and hepatic carcinogenesis in the F344/NCr rat.恶唑烷二酮类抗惊厥药三甲双酮和二甲双酮以及巴比妥类同系物5,5-二甲基巴比妥酸对F344/NCr大鼠中N-亚硝基二乙胺引发的肾和肝癌变的影响。
Arch Toxicol. 1992;66(6):413-22. doi: 10.1007/BF02035132.
5
Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists.新型 3-恶唑烷二酮-6-萘基-2-吡啶酮作为有效且口服生物利用度的 EP3 受体拮抗剂的构效关系研究。
Bioorg Med Chem Lett. 2011 May 15;21(10):2806-11. doi: 10.1016/j.bmcl.2011.03.107. Epub 2011 Apr 5.
6
Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.[18F]比卡鲁胺、4-[76Br]溴比卡鲁胺和4-[76Br]溴硫比卡鲁胺作为用于前列腺癌成像的非甾体雄激素的合成及生物学评价
J Med Chem. 2007 Mar 8;50(5):1028-40. doi: 10.1021/jm060847r.
7
Synthesis of irreversibly binding bicalutamide analogs for imaging studies.用于成像研究的不可逆结合比卡鲁胺类似物的合成。
Tetrahedron Lett. 2005 Jul 11;46(28):4821-4823. doi: 10.1016/j.tetlet.2005.04.143.
8
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial.在 CHHiP 试验中，比卡鲁胺与促黄体激素释放激素（LHRH）类似物联合放射治疗的疗效和副作用的非随机比较。
Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):305-315. doi: 10.1016/j.ijrobp.2021.12.160. Epub 2022 Jan 10.
9
Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents.比卡鲁胺作为一种雄激素阻断剂，具有促进男跨女青春期变性青少年女性化的次要作用。
J Adolesc Health. 2019 Apr;64(4):544-546. doi: 10.1016/j.jadohealth.2018.10.296. Epub 2019 Jan 4.
10
A pharmacological comparison of the optical isomers of 5-ethyl-5-methyl-2,4-oxazolidinedione and of 3,5-dimethyl-5 ethyl-2,4-oxazolidinedione (paramethadione, paradione).
J Pharmacol Exp Ther. 1955 Feb;113(2):238-40.
引用本文的文献
1
Conformational Landscape, Polymorphism, and Solid Forms Design of Bicalutamide: A Review.比卡鲁胺的构象景观、多态性及固体形态设计：综述
Molecules. 2025 Sep 18;30(18):3793. doi: 10.3390/molecules30183793.
本文引用的文献
1
Synthesis of irreversibly binding bicalutamide analogs for imaging studies.用于成像研究的不可逆结合比卡鲁胺类似物的合成。
Tetrahedron Lett. 2005 Jul 11;46(28):4821-4823. doi: 10.1016/j.tetlet.2005.04.143.
2
Structural basis for antagonism and resistance of bicalutamide in prostate cancer.比卡鲁胺在前列腺癌中拮抗作用和耐药性的结构基础
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6201-6. doi: 10.1073/pnas.0500381102. Epub 2005 Apr 15.
3
A selective androgen receptor modulator for hormonal male contraception.一种用于激素男性避孕的选择性雄激素受体调节剂。
J Pharmacol Exp Ther. 2005 Feb;312(2):546-53. doi: 10.1124/jpet.104.075424. Epub 2004 Sep 3.
4
Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.新型选择性雄激素受体调节剂、5α-还原酶抑制剂非那雄胺及抗雄激素药物羟基氟他胺在成年大鼠体内的药理作用比较：良性前列腺增生的新研究方法
Endocrinology. 2004 Dec;145(12):5420-8. doi: 10.1210/en.2004-0627. Epub 2004 Aug 12.
5
A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.一种基于配体的方法来确定雄激素受体的定量构效关系。
J Med Chem. 2004 Jul 15;47(15):3765-76. doi: 10.1021/jm0499007.
6
Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.代谢稳定的选择性雄激素受体调节剂的设计、合成及生物学特性研究
J Med Chem. 2004 Feb 12;47(4):993-8. doi: 10.1021/jm030336u.
7
Pharmacodynamics of selective androgen receptor modulators.选择性雄激素受体调节剂的药效学
J Pharmacol Exp Ther. 2003 Mar;304(3):1334-40. doi: 10.1124/jpet.102.040840.
8
Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor.乙酰硫代鲁米特的药理学、药代动力学及代谢，一种新型雄激素受体非甾体激动剂
J Pharmacol Exp Ther. 2003 Mar;304(3):1323-33. doi: 10.1124/jpet.102.040832.
9
Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.利用多分子动力学模拟和对接研究对与睾酮及非甾体配体结合的人雄激素受体配体结合域进行同源建模。
J Med Chem. 2001 May 24;44(11):1729-40. doi: 10.1021/jm0005353.
10
Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.用于雄激素受体的手性非甾体亲和配体。1. B芳香环带有亲电基团的比卡鲁胺类似物。
J Med Chem. 2000 Feb 24;43(4):581-90. doi: 10.1021/jm990027x.
Zotero 插件